Filing Details

Accession Number:
0000886163-17-000138
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-11-17 17:14:53
Reporting Period:
2017-11-16
Accepted Time:
2017-11-17 17:14:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
886163 Ligand Pharmaceuticals Inc LGND Pharmaceutical Preparations (2834) 770160744
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1223000 W John Kozarich 3911 Sorrento Valley Boulevard, Ste 110
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-11-16 5,000 $141.71 35,649 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The reporting person contributed LGND common stock to an exchange fund in exchange for shares of the exchange fund. The LGND common stock was valued at $141.71 per share for the purpose of determining the number of shares of the exchange fund issuable to the reporting person.